Yodoshi et al. found a strong association between positive ANA and higher steatosis scores, while Adams et al. demonstrated that ANA-positive NASH patients had more severe liver necroinflammation and fibrosis than ANA-negative patients (27, 28). The gene discussed is BTG3; the disease is metabolic dysfunction-associated steatohepatitis.